Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies said after the close of the market on Monday that its preliminary second quarter revenues grew about 11 percent year over year, exceeding previous guidance.

The company also announced a $50 million underwritten public offering of its common stock, pursuant to an existing shelf registration statement. In connection with the offering, NanoString said it also expects to grant underwriters a 30-day option to purchase up to $7.5 million worth of additional common shares.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.